About Villaris Therapeutics
Villaris Therapeutics is a company based in Cary (United States) founded in 2019 was acquired by Incyte in October 2022.. Villaris Therapeutics offers products and services including Anti-IL-15R Antibody.
- Headquarter Cary, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Villaris Therapeutics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Villaris Therapeutics
Villaris Therapeutics offers a comprehensive portfolio of products and services, including Anti-IL-15R Antibody. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets immune cells to treat vitiligo and autoimmune diseases effectively.
Funding Insights of Villaris Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Villaris Therapeutics
Villaris Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Incyte. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecules are developed for cancer and skin disease treatments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Villaris Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Villaris Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Villaris Therapeutics Comparisons
Competitors of Villaris Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Villaris Therapeutics
When was Villaris Therapeutics founded?
Villaris Therapeutics was founded in 2019.
Where is Villaris Therapeutics located?
Villaris Therapeutics is headquartered in Cary, United States. It is registered at Cary, North Carolina, United States.
Who is the current CEO of Villaris Therapeutics?
Andrea Epperly is the current CEO of Villaris Therapeutics.
What does Villaris Therapeutics do?
Villaris Therapeutics was founded in 2019 and is based in Cary, United States. Antibody therapeutics targeting the IL-15 signaling pathway are developed to address vitiligo by inhibiting autoimmune memory T cells that cause disease reemergence. Operations center on biotechnology within the dermatology sector, with a focus on humanized anti-IL-15R antibodies for immune modulation. Leadership is provided by CEO Andrea Epperly.
What products or services does Villaris Therapeutics offer?
Villaris Therapeutics offers Anti-IL-15R Antibody.
Who are Villaris Therapeutics's investors?
Villaris Therapeutics has 1 investor. Key investors include Incyte.